NC
National Center for Tumor Diseases Heidelberg at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
National Center for Tumor Diseases Heidelberg takes part in 3 sessions at ESMO 2026 in Madrid. Its sessions cover metastatic uveal melanoma, a melanoma of the eye, and first-line treatment in advanced prostate and urothelial cancer. It explores the biology driving uveal melanoma and a collaborative approach to turning trial data into care, and joins a mentoring exchange for oncologists.
| Organization | ESMO 2026 Attendance |
|---|---|
NC National Center for Tumor Diseases Heidelberg Heidelberg, Germany | |
Cancer centre in Heidelberg, Germany, run jointly by the German Cancer Research Center, Heidelberg University Hospital and the university's medical faculty. | Satellite Fri Oct 23 18:20–18:30 Metastatic Uveal Melanoma (mUM): Clinical Snapshot and Biologic Drivers Melanoma & skin cancers Talk Sat Oct 24 11:58–12:05 Satellite Sun Oct 25 14:05–14:23 Translating data into care through a collaborative approach Genitourinary cancers Satellite Sun Oct 25 14:23–14:28 Audience Q&A: Advanced urothelial cancer Genitourinary cancers |
Instantly find 20 buyers from National Center for Tumor Diseases Heidelberg
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction